Nxstage Medical, Inc. (NXTM) Tops Q2 EPS by 1c; Guides Q3 EPS, Revs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Lazard Capital Downgrades NxStage Medical (NXTM) to Neutral
July 26, 2013 8:36 AM EDTLazard Capital downgraded NxStage Medical (NASDAQ: NXTM) from Buy to Neutral.
For an analyst ratings summary and ratings history on NxStage Medical click here. For more ratings news on NxStage Medical click here.
Shares of NxStage Medical closed at $13.59 yesterday, with a 52 week range of $10.15-$16.25.... More
